Clinical trials - Press Releases

Date	Title	Company
19-Sep-2023	Thermosome Establishes High-Profile Clinical Advisory Board	Thermosome GmbH
15-Sep-2023	Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague	Curasight A/S
14-Sep-2023	MODERNA EXPANDS THE FIELD OF MRNA MEDICINE WITH POSITIVE CLINICAL RESULTS ACROSS CANCER, RARE DISEASE, AND INFECTIOUS DISEASE	Moderna
14-Sep-2023	Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease	Moderna
14-Sep-2023	Lundbeck presents clinical advances in migraine prevention with positive trial results at international headache congress	H. Lundbeck A/S
14-Sep-2023	Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine	Curia
13-Sep-2023	Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart	Phastar
13-Sep-2023	AbbVie's SKYRIZI® (risankizumab) Met All Primary and Secondary Endpoints Versus Stelara® (ustekinumab) in Head-to-Head Study in Crohn's Disease	AbbVie
12-Sep-2023	Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)	AstraZeneca
12-Sep-2023	HUTCHMED Highlights Presentation of Results from the Phase IIIb Trial of Savolitinib at the 2023 World Conference of Lung Cancer	HUTCHMED
12-Sep-2023	AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia	AlgoTherapeutix (AlgoTx)
12-Sep-2023	HUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China	HUTCHMED
08-Sep-2023	Novotech Publishes Nasopharyngeal Carcinoma Global Clinical Trial Landscape Report	Novotech
08-Sep-2023	MERCURY-3 trial data show Roclanda® – latanoprost/netarsudil fixed dose combination – demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension1	Santen
08-Sep-2023	Positive interim data from phase lla trial of FG001 in head & neck cancer presented as a case report at the World Molecular Imaging Congress in Prague	FluoGuide
08-Sep-2023	Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury	Neuroplast
08-Sep-2023	Actimed Therapeutics announces FDA approval of its Investigational New Drug application for Phase 2b/3 IMPACT clinical trials of S-pindolol benzoate to treat cancer cachexia	Actimed Therapeutics
08-Sep-2023	Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer	Ariceum Therapeutics
06-Sep-2023	Vitestro starts largest-scale clinical trial globally for its autonomous blood drawing device, with enrolment of first patients in A.D.O.P.T.	Vitestro
05-Sep-2023	BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds	BellaSeno GmbH